The Beauty Health Company (SKIN) Reports In-Line Q4 EPS

The Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $96.8 million versus the consensus estimate of $87.22 million.

GUIDANCE:

The Beauty Health Company sees Q1 2024 revenue of $77-83 million, versus the consensus of $85.5 million.

Financial Guidance as of March 2024

__________________________

(1) See "Non-GAAP Financial Measures" below.

Financial guidance reflects the following assumptions:

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight